BioNTech ١٤ يناير ٢٠٢٦ JPM26: BioNTech gears up for multiproduct oncology status by 2030 - Clinical Trials Arena
Endpoints News ٩ ديسمبر ٢٠٢٥ #SABCS25: BioNTech, BMS unwrap Phase 2 data for PD-L1xVEGF-A bispecific in breast cancer